Medication use lower 2 years after combined iStent implantation, cataract surgery

A large observational study demonstrated that glaucoma patients implanted with the Glaukos iStent in combination with cataract surgery achieved a significant reduction in the use of topical medications over a follow-up of at least 2 years.

Nearly 3,000 patients who had undergone the combined procedure in one or both eyes were selected from a U.S. managed care network and compared with a similar number of glaucoma patients who had undergone cataract surgery alone. At baseline, 41.2% of patients in the combined group were taking no topical medications, while the rest were receiving one to three topical agents.